Provention Bio Inc. (PRVB) Tops Q3 EPS by 8c
Provention Bio Inc. (NASDAQ: PRVB) reported Q3 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Provention Bio Inc. (PRVB) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share